H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Novartis Institutes for BioMedical Research, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPNovartis Institutes for BioMedical Research, Inc.
Total filings80,813964
Certified %98.23%96.37%
Denied %1.09%0.93%
Withdrawn %0.61%1.76%
Cert-withdrawn %0.07%0.93%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePANJ

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Novartis Institutes for BioMedical Research, Inc.

DOL case-status mix.

Outcome breakdown: Certified 96.4%, Cert-withdrawn 0.9%, Withdrawn 1.8%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified96.4%
Cert-withdrawn0.9%
Withdrawn1.8%
Denied0.9%
Certified96.4%
Cert-withdrawn0.9%
Withdrawn1.8%
Denied0.9%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Novartis Institutes for BioMedical Research, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201065
FY201154
FY201264
FY201358
FY201480
FY201569
FY201676
FY201782
FY201862
FY201970
FY20204
FY20219
FY20226
FY202313
FY2024106
FY202592
FY202654

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Novartis Institutes for BioMedical Research, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.